Cargando…
Coagulopathy in COVID-19: Focus on vascular thrombotic events
SARS-CoV-2 causes a phenotype of pneumonia with diverse manifestation, which is termed as coronavirus disease 2019 (COVID-19). An impressive high transmission rate allows COVID-19 conferring enormous challenge for clinicians worldwide, and developing to a pandemic level. Combined with a series of co...
Autores principales: | Shi, Wei, Lv, Jiagao, Lin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362808/ https://www.ncbi.nlm.nih.gov/pubmed/32681845 http://dx.doi.org/10.1016/j.yjmcc.2020.07.003 |
Ejemplares similares
-
COVID-19 Associated Coagulopathy and Thrombotic Complications
por: Mezalek, Zoubida Tazi, et al.
Publicado: (2020) -
COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection
por: Sharma, Swati, et al.
Publicado: (2022) -
The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases
por: Szilveszter, Mónika, et al.
Publicado: (2023) -
Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
por: Touyz, Rhian M., et al.
Publicado: (2018) -
The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2022)